Efficacy and Safety in Producing and Using Medicinal Plants and Herbal Drugs
Tārīkh-i pizishkī i.e., Medical History,
Vol. 12 No. 45 (1399),
9 January 2021
,
Page 1-15
https://doi.org/10.22037/mhj.v12i45.29956
Abstract
Background and Aim: Despite the tendency to use herbs and herbal medicine, less scientific documents have been published on the problems and necessities of using these types of drugs, especially on side effects, plant health and even drug interactions.
Materials and Methods: In this study, in order to review and critique the scientific documents related to the challenges of production and consumption of medicinal plants, review studies by examining sources by exploring scientific sources from Science Direct, Google Scholar, PubMed, Magiran and SID databases. The original Gigalib Digital Library was used to prepare the original reports. The terms "herbs", "adverse effects", "side effects", "drug-herbal interactions" and "complementary medicine" were used to search between 2000 and 2018. The fundamental questions of the study were whether the medicinal plants and herbal medicines offered have the necessary health and efficiency for public consumption? And will indiscriminate use of chemical drugs increase the effectiveness of drugs or not?
Findings: Results indicated the multiplicity of scientific reports related to the medicinal and therapeutic effects of medicinal plants. Factors such as advertising, culture and dislike of chemical drugs are involved in the tendency to use them. There were numerous reports of unhealthy production and fraud in medicinal plants and lack of expertise in prescribing and medication of medicinal plants and herbal medicines.
Conclusion: The use of herbal medicines is not without risk. Conscious use of herbs and attention to their possible side effects and drug interactions is recommended. Standardization of medicinal plant production processes is also necessary to ensure part of their efficiency and safety.
- Medicinal Plants; Drug Interactions; Medicinal Complementary; Side Effects; Adverse Effects
How to Cite
References
- Hussin AH. Adverse Effects of Herbs and Drug-Herbal Interactions. Malaysian Journal of Pharmacy. 2001; 1(2): 39-44.
- Saad B, Zaid H, Shanak S, and Kadan S. Introduction to medicinal plant safety and efficacy. In Anti-diabetes and Anti-obesity Medicinal Plants and Phytochemicals. 2017; 21-55. Springer, Cham.
- Ebadi MT, Abbasian J. Global trade of medicinal and Aromatic plants – a review. 2th national festival and exhibition in herbal, natural products and Traditional medicine. Especial issue newsletter. 2014; 186-197.
- Enioutina EY, Salis ER, Job KM, Gubarev MI, Krepkova LV, Sherwin CMT. Herbal medicines: Challenges in the Modern World. Part 5. Status and current directions of complementary and alternative herbal medicine worldwide. Expert Review of Clinical Pharmacology. 2017; 10(3): 327-338.
- Izzo AA, Hoon Kim S, Radhakrishnan R, Williamson EM. A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies. Phytotherapy Research. 2016; 30(5):691-700.
- Wu CH, Wang CC, Kennedy J. Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clinical Therapy. 2011; 33(11): 1749–58.
- Haq I. Safety of medicinal plants. Pakistan journal of medicinal research. 2004; 43(4): 203-210.
- Nessabian S, Gholamhoseini T, and Jabalameli F.. Comparison of relative advantage in medicinal plant export to other exporter countries (case study: Fennel, Anisum, coriandrum). Economic Modelling. 2012; 20(6): 75-92.
- Manindla S, Prasad KVSRG, and Koganti B. Herb-drug interactions: an overview of mechanisms and clinical aspects. International journal of pharmaceutical science and research. 2016; 7(9): 3576-3586.
- Ve´gh A, Fittler A, Vida RG, Miseta I, Taka´cs G, and Botz L. Identification and evaluation of drug–supplement interactions in Hungarian hospital patients. International Journal of Clinical Pharmacology. 2014; 36(2): 451-459.
- Nasri H, and Shirzad H. Toxicity and safety of medicinal plants. Journal of Herbal Medicine of Pharmacology. 2013; 2(2): 21-22.
- Chizzola R, Michitsch H, and Franz C. Monitoring of metallic micronutrients and heavy metals in herbs, spices and medicinal plants from Austria. European Food Research and Technology; 2003, 216(5): 407–411.
- Fugh‐Berman A, and Ernst E. Herb–drug interactions: review and assessment of report reliability. British journal of clinical pharmacology. 2001; 52(5): 587-595.
- Posadzki P, Watson LK and Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clinical Medicine. 2013; 13(1): 7–12.
- Elvin-Lewis M. Should we be concerned about herbal remedies. Journal of ethnopharmacology. 2001; 75(2-3): 141-164.
- Valli G, Elsa-Grace MD, and Giardina V. Benefits, Adverse Effects and Drug Interactions of Herbal Therapies with Cardiovascular Effects. Journal of the American College of Cardiology. 2002; 39(7): 1083-1095.
- Mantle D, Gok MA, and Lennard TW. Adverse and beneficial effects of plant extracts on skin and skin disorders. Adverse Drug Reactions and Toxicological Reviews. 2001; 20(2): 89-103.
- Falzon CC, and Balabanova A. Phytotherapy: An introduction to herbal medicine. Primary Care: Clinics in Office Practice. 2017; 44(2): 217-227.
- McGovern TW, and LaWarre S. Botanical briefs: garlic – Allium sativum. Cutis 2001, 67(3): 193–194.
- Ariga T, and Seki T. Antithrombotic and anticancer effects of garlic-derived sulfur compounds: a review, Biofactors, 2006; 26: 93–103.
- Shukla Y, Kalra N. Cancer chemoprevention with garlic and its constituents, Cancer Letters. 2007; 247: 167–181.
- Ross SA, Finley JW, and Milner JA. Allyl sulfur compounds from garlic modulate aberrant crypt formation. Journal of Nutrition. 2006; 136: 852–854.
- Wargovich MJ. Diallylsulfide and allylmethylsulfide are uniquely effective among organosulfur compounds in inhibiting CYP2E1 protein in animal models. Journal of Nutrition. 2006; 136: 832–834.
- Milner JA. Preclinical perspectives on garlic and cancer. Journal of Nutrition. 2006; 136: 827–831.
- Ahmad MS, and Ahmed N. Antiglycation properties of aged garlic extract: possible role in prevention of diabetic complications. Journal of Nutrition. 2006; 136: 796–799.
- Rahman K, Lowe GM. Garlic and cardiovascular disease: a critical review. Journal of Nutrition. 2006; 136: 736–740.
- Chauhan NB. Multiplicity of garlic health effects and Alzheimer's disease, Journal of Nutrition Health Aging, 2005; 9: 421–432.
- Atmaca G. Antioxidant effects of sulfur-containing amino acids, Yonsei Medical Journal. 2004; 45: 776–788.
- Borek C. Garlic reduces dementia and heart-disease risk. Journal of Nutrition, 2006; 136: 810–812.
- Borrelli F, Capasso R, and Izzo AA. Garlic (Allium sativum L.): asverse effects and drug interactions in humans. Mol. Nutr. Food Res. 2007; 51: 1386 – 1397.
- Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. Journal of Clinical Pharmacy and Therapeutics. 2002; 27: 391–401
- Davis M. Herbal remedies: adverse effects and drug interactions. American Family Physician, 1999; 59(5): 1239-1244.
- Tan MS, Yu JT, Tan CC, Wang HF, Meng XF, Wang C, Jiang T, Zhu XC, Tan L. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. Journal of Alzheimer's Disease. 2015; 43(2): 589-603.
- Borrelli F, Izzo AA. Herb–drug interactions with St John’s wort (Hypericum perforatum): an update on clinical observations. The AAPS journal. 2009; 11(4): 710-727.
- Kaye AD, Clarke RC, Sabar R, Vig S, Dhawan KP, Hofbauer R, Kaye AM. Herbal medicines: current trends in anesthesiology practice—a hospital survey. Journal of clinical anesthesia. 2000; 12(6): 468-471.
- Izzo AA, and Ernest E. Interactions Between Herbal Medicines and Prescribed Drugs, A Systematic Review. Drugs 2001; 61(15): 2163-2175.
- Fugh-Berman A. Herb-drug interactions. The Lancet. 2000; 355(9198): 134-138.
- Zhang M, Holman CD, Preen DB, and Brameld K. Repeat adverse drug reactions causing hospitalization in older Australians: a population‐based longitudinal study 1980–2003. British journal of clinical pharmacology. 2007; 63(2): 163-170.
- Abstract Viewed: 634 times
- pdf (فارسی) Downloaded: 551 times